Medicale Corp.
Data quality: 83%
MCLE
OTC
Services
Health Services
$0.10
$0.00
(0.00%)
Mkt Cap: 592,000.0
Price
$0.10
Mkt Cap
592,000.0
Day Range
$0.10 — $0.10
52-Week Range
$0.02 — $6.35
Volume
19,160
Open $0.10
50D / 200D Avg
$0.21
53.42% below
50D / 200D Avg
$0.14
30.22% below
Quick Summary
Key Takeaways
Negative free cash flow of -19,748.0
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
N/A
ROICN/A
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
N/A
Current Ratio0.00
Interest Coverage-2.66
Valuation
PE (TTM)
-17.53
Below sector avg (-1.17)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Services sector median (502 peers)
Peer Comparison
vs Services sector median (502 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -17.5 | -1.2 |
| P/B | — | 1.4 |
| ROE % | — | -16.0 |
| Net Margin % | — | -19.4 |
| Rev Growth 5Y % | — | 4.0 |
| D/E | — | 0.4 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -33,763.0 |
| ROE | N/A | ROA | N/A |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -19,748.0 |
| ROIC | N/A | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 0.00 |
| Interest Coverage | -2.66 | Asset Turnover | N/A |
| Working Capital | -32,202 | Tangible Book Value | -145,376 |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -17.53 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -3.34% | ||
| Market Cap | 592,000.0 | Enterprise Value | 592,000.0 |
| Per Share | |||
| EPS (Diluted TTM) | -0.01 | Revenue / Share | N/A |
| FCF / Share | 0.00 | OCF / Share | 0.00 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 58.49% |
| SBC-Adj. FCF | N/A | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | — | — | — | 0.0 | 0.0 |
| Net Income | -41,153.0 | -58,213.0 | -37,138.0 | -46,419.0 | -32,152.0 |
| EPS (Diluted) | -0.01 | -0.01 | -0.01 | -0.01 | — |
| Gross Profit | — | — | — | — | — |
| Operating Income | -33,493.0 | -54,707.0 | -37,593.0 | -46,419.0 | -32,152.0 |
| EBITDA | — | — | — | — | — |
| R&D Expenses | — | — | — | — | — |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | — | — | — |
| Interest Expense | 7,501.0 | 3,506.0 | — | — | — |
| Income Tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 0.0 | 159.0 | 159.0 | 0.0 | 28,275.0 |
| Total Liabilities | 140,086.0 | 99,092.0 | — | — | — |
| Shareholders' Equity | -140,086.0 | -98,933.0 | -40,720.0 | -54,774.0 | -8,355.0 |
| Total Debt | — | — | — | — | — |
| Cash & Equivalents | — | — | — | — | 18,475.0 |
| Current Assets | 0.0 | 159.0 | 159.0 | 0.0 | 18,675.0 |
| Current Liabilities | 33,652.0 | 15,507.0 | 40,879.0 | 54,774.0 | 36,630.0 |
{"event":"ticker_viewed","properties":{"ticker":"MCLE","listing_kind":"stock","pathname":"/stocks/mcle","exchange":"OTC","country":"US"}}